Literature DB >> 6737802

The role of the spleen in tumor bearing host: I. Characterization of spleen cells in tumor-bearing mice.

H Yamagishi, T Oka, I Hashimoto, N R Pellis, B D Kahan.   

Abstract

Morphologic changes of the spleen and dynamic changes of biologic activity of spleen cells from C3H/HeJ mice bearing methylcholanthrene induced fibrosarcoma (MCA-F) were investigated in different stages of tumor growth, using local adoptive transfer assay (LATA). The spleen size, weight and the number of spleen cells increased with the tumor growth. In early and late stages of tumor growth, tumor-bearing mice possessed non-specific tumor-enhancing cells which were radioresistant (700 rads), phagocytic and adherent, suggesting that they were macrophages. On the other hand, in middle stages of tumorgenesis, tumor-bearing mice possessed specific cytotoxic cells which were radiosensitive (700 rads) and anti-Thy 1.2 serum positive, suggesting that they were T-cells. Thus, the appearance of tumor-enhancing cells was earlier than cytotoxic cells in MCA-F bearing host, and the balance of tumor-enhancing and cytotoxic cells may influence the tumor outgrowth in different stages of tumorgenesis. The spleen serves as a reservoir of factors which either abrogate cell mediated resistance or stimulate neoplastic growth, or as the source of cytotoxic cells, at certain times of tumor burden.

Entities:  

Mesh:

Year:  1984        PMID: 6737802     DOI: 10.1007/BF02469605

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  Inhibition of rat mixed lymphocyte cultures by suppressor macrophages.

Authors:  J R Oehler; R B Herberman; D A Campbell; J Y Djeu
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

3.  Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

4.  Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.

Authors:  B L Pope; R B Whitney; J G Levy; D G Kilburn
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

5.  Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors.

Authors:  H Kirchner; R B Herberman; M Glaser; D H Lavrin
Journal:  Cell Immunol       Date:  1974-07       Impact factor: 4.868

6.  Tumor-protective and -facilitating antigens from 3 M KCl-solubilized tumor extracts.

Authors:  H Yamagishi; N R Pellis; B D Kahan
Journal:  J Surg Res       Date:  1979-04       Impact factor: 2.192

7.  The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.

Authors:  E W Lamon; H M Skurzak; E Klein
Journal:  Int J Cancer       Date:  1972-11       Impact factor: 7.396

8.  Evidence for splenic suppressor cells in C3H/He, T-cell-deprived C3H/He, and nude mice bearing a 3-methylcholanthrene-induced fibrosarcoma.

Authors:  M F Poupon; J P Kolb; G Lespinats
Journal:  J Natl Cancer Inst       Date:  1976-12       Impact factor: 13.506

9.  Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.

Authors:  A E Eggers; J R Wunderlich
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

10.  Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells.

Authors:  M Yagello; G Lespinats; W H Fridman
Journal:  Int J Cancer       Date:  1978-08-15       Impact factor: 7.396

  10 in total
  2 in total

1.  The role of the spleen in tumor bearing host: II. The influence of splenectomy in mice.

Authors:  H Yamagishi; T Oka; I Hashimoto; N R Pellis; B D Kahan
Journal:  Jpn J Surg       Date:  1984-01

2.  cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.

Authors:  Sanjay Mishra; Manish Charan; Rajni Kant Shukla; Pranay Agarwal; Swati Misri; Ajeet K Verma; Dinesh K Ahirwar; Jalal Siddiqui; Kirti Kaul; Neety Sahu; Kunj Vyas; Ayush Arpit Garg; Anum Khan; Wayne O Miles; Jonathan W Song; Nidhi Bhutani; Ramesh K Ganju
Journal:  J Exp Clin Cancer Res       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.